2018 |
09/14 | (IR情報)15:00 人事異動のお知らせ |
09/10 | 2,409 | 2,420 | 2,391 | 2,415 | +0.25% | 68,300 | 695億5200万 | -4.58% |
09/07 | 2,347 | 2,409 | 2,341 | 2,409 | +2.51% | 134,000 | 693億7920万 | -5.05% |
09/06 | 2,342 | 2,364 | 2,331 | 2,350 | +0.47% | 49,300 | 676億8000万 | -7.63% |
09/05 | 2,300 | 2,350 | 2,292 | 2,339 | +1.34% | 77,700 | 673億6320万 | -8.45% |
09/04 | 2,334 | 2,336 | 2,305 | 2,308 | -0.99% | 85,400 | 664億7040万 | -10.09% |
09/03 | 2,375 | 2,375 | 2,330 | 2,331 | -1.56% | 104,200 | 671億3280万 | -9.76% |
08/31 | 2,358 | 2,385 | 2,352 | 2,368 | +0.3% | 76,600 | 681億9840万 | -9.1% |
08/30 | 2,366 | 2,383 | 2,345 | 2,361 | -0.04% | 153,000 | 679億9680万 | -10.06% |
08/29 | 2,357 | 2,370 | 2,350 | 2,362 | +0.08% | 210,300 | 680億2560万 | -10.67% |
08/28 | 2,403 | 2,425 | 2,343 | 2,360 | -12.69% | 491,200 | 679億6800万 | -11.24% |
08/27 | (IR情報)15:00 抗HIV薬6品の日本国内における独占的開発・商業化権に関する契約及び独占的販売権に関する契約の解消に向けた意思確認書の締結について |
08/27 | 2,701 | 2,707 | 2,663 | 2,703 | +0.07% | 13,100 | 778億4640万 | +1.2% |
08/24 | 2,742 | 2,743 | 2,681 | 2,701 | -0.63% | 18,700 | 777億8880万 | +1.2% |
08/23 | 2,713 | 2,749 | 2,703 | 2,718 | +0.11% | 22,000 | 782億7840万 | +1.95% |
08/22 | 2,621 | 2,717 | 2,621 | 2,715 | +3.71% | 35,700 | 781億9200万 | +1.88% |
08/21 | 2,602 | 2,623 | 2,597 | 2,618 | -0.49% | 13,800 | 753億9840万 | -1.69% |
08/20 | 2,620 | 2,631 | 2,605 | 2,631 | 0% | 13,900 | 757億7280万 | -1.24% |
08/17 | 2,630 | 2,648 | 2,612 | 2,631 | +0.04% | 15,600 | 757億7280万 | -1.24% |
08/16 | 2,633 | 2,664 | 2,604 | 2,630 | -1.31% | 25,100 | 757億4400万 | -1.31% |
08/15 | 2,649 | 2,667 | 2,617 | 2,665 | -0.07% | 21,200 | 767億5200万 | +0.08% |
08/14 | 2,599 | 2,667 | 2,598 | 2,667 | +2.3% | 29,800 | 768億960万 | +0.15% |
08/13 | 2,576 | 2,614 | 2,576 | 2,607 | +0.7% | 28,000 | 750億8160万 | -2.18% |
08/10 | 2,604 | 2,606 | 2,567 | 2,589 | -0.19% | 28,400 | 745億6320万 | -3% |
08/09 | 2,568 | 2,598 | 2,557 | 2,594 | +0.78% | 20,800 | 747億720万 | -2.85% |
08/08 | 2,608 | 2,625 | 2,573 | 2,574 | -2.24% | 20,100 | 741億3120万 | -3.78% |
08/07 | 2,561 | 2,634 | 2,561 | 2,633 | +2.97% | 25,300 | 758億3040万 | -1.75% |
08/06 | 2,555 | 2,587 | 2,554 | 2,557 | -1.24% | 32,900 | 736億4160万 | -4.63% |
08/03 | 2,611 | 2,627 | 2,583 | 2,589 | -1.26% | 35,000 | 745億6320万 | -3.61% |
08/02 | 2,629 | 2,684 | 2,608 | 2,622 | -1.09% | 34,300 | 755億1360万 | -2.56% |
08/01 | 2,649 | 2,695 | 2,649 | 2,651 | -1.78% | 60,600 | 763億4880万 | -1.63% |
07/31 | 2,773 | 2,823 | 2,697 | 2,699 | -6.06% | 78,500 | 777億3120万 | +0.07% |
07/30 | (IR情報)15:00 2018年12月期第2四半期決算参考資料 |
07/30 | (IR情報)15:00 平成30年12月期第2四半期決算短信〔日本基準〕(非連結) |
07/30 | 2,870 | 2,873 | 2,803 | 2,873 | +0.1% | 99,400 | 827億4240万 | +6.49% |
07/27 | 2,837 | 2,881 | 2,798 | 2,870 | +1.16% | 40,600 | 826億5600万 | +6.61% |
07/26 | 2,786 | 2,838 | 2,727 | 2,837 | +3.05% | 35,200 | 817億560万 | +5.58% |
07/25 | 2,692 | 2,761 | 2,677 | 2,753 | +3.61% | 48,300 | 792億8640万 | +2.53% |
07/24 | 2,670 | 2,670 | 2,622 | 2,657 | +0.38% | 36,900 | 765億2160万 | -1.08% |
07/23 | 2,600 | 2,670 | 2,600 | 2,647 | +0.57% | 23,900 | 762億3360万 | -1.67% |
07/20 | 2,662 | 2,681 | 2,613 | 2,632 | -1.9% | 39,300 | 758億160万 | -2.52% |
07/19 | 2,676 | 2,696 | 2,650 | 2,683 | +0.26% | 25,600 | 772億7040万 | -0.89% |
07/18 | 2,648 | 2,679 | 2,631 | 2,676 | +1.29% | 18,400 | 770億6880万 | -1.33% |
07/17 | 2,625 | 2,662 | 2,608 | 2,642 | +0.65% | 20,600 | 760億8960万 | -2.8% |
07/13 | 2,631 | 2,631 | 2,580 | 2,625 | -0.72% | 39,800 | 756億 | -3.56% |
07/12 | 2,618 | 2,649 | 2,592 | 2,644 | +2.01% | 33,600 | 761億4720万 | -3.08% |
07/11 | 2,642 | 2,670 | 2,570 | 2,592 | -2.41% | 49,000 | 746億4960万 | -5.09% |
07/10 | 2,733 | 2,740 | 2,655 | 2,656 | -2.82% | 39,400 | 764億9280万 | -2.92% |
07/09 | 2,693 | 2,734 | 2,676 | 2,733 | +1.49% | 40,600 | 787億1040万 | -0.18% |
07/06 | 2,649 | 2,697 | 2,624 | 2,693 | +2.67% | 21,600 | 775億5840万 | -1.5% |
07/05 | 2,693 | 2,693 | 2,608 | 2,623 | -3.03% | 18,900 | 755億4240万 | -4.13% |
07/04 | 2,688 | 2,715 | 2,685 | 2,705 | -0.51% | 22,800 | 779億400万 | -1.42% |
07/03 | 2,642 | 2,730 | 2,642 | 2,719 | +2.68% | 40,500 | 783億720万 | -0.98% |
07/02 | 2,692 | 2,705 | 2,639 | 2,648 | -1.63% | 24,700 | 762億6240万 | -3.67% |
06/29 | 2,708 | 2,731 | 2,680 | 2,692 | -0.59% | 13,200 | 775億2960万 | -2.36% |
06/28 | (IR情報)15:00 NK-1受容体アンタゴニスト(JTS-661)の開発中止及びMenlo Therapeutics社とのライセンス契約の解約について |
06/28 | 2,690 | 2,714 | 2,670 | 2,708 | -0.77% | 17,400 | 779億9040万 | -2.03% |
06/27 | 2,692 | 2,745 | 2,692 | 2,729 | +1.3% | 15,400 | 785億9520万 | -1.55% |
06/26 | 2,702 | 2,709 | 2,684 | 2,694 | -0.81% | 14,100 | 775億8720万 | -2.99% |
06/25 | 2,743 | 2,743 | 2,705 | 2,716 | -0.04% | 20,300 | 782億2080万 | -2.37% |
06/22 | 2,737 | 2,761 | 2,701 | 2,717 | -1.63% | 34,400 | 782億4960万 | -2.55% |
06/21 | 2,759 | 2,796 | 2,755 | 2,762 | -0.79% | 11,400 | 795億4560万 | -1.15% |
06/20 | 2,764 | 2,786 | 2,758 | 2,784 | +0.14% | 16,000 | 801億7920万 | -0.54% |
06/19 | 2,798 | 2,811 | 2,754 | 2,780 | -0.93% | 20,500 | 800億6400万 | -0.89% |
06/18 | 2,841 | 2,854 | 2,792 | 2,806 | -1.23% | 7,700 | 808億1280万 | -0.28% |
06/15 | 2,838 | 2,864 | 2,828 | 2,841 | +0.78% | 28,500 | 818億2080万 | +0.71% |
06/14 | 2,785 | 2,824 | 2,785 | 2,819 | +0.46% | 11,100 | 811億8720万 | -0.07% |
06/13 | 2,830 | 2,850 | 2,760 | 2,806 | -0.11% | 21,300 | 808億1280万 | -0.53% |
06/12 | 2,781 | 2,817 | 2,750 | 2,809 | +1.85% | 39,200 | 808億9920万 | -0.43% |
06/11 | 2,758 | 2,782 | 2,746 | 2,758 | 0% | 19,500 | 794億3040万 | -2.3% |
06/08 | 2,757 | 2,762 | 2,714 | 2,758 | +1.14% | 38,300 | 794億3040万 | -2.44% |
06/07 | 2,716 | 2,730 | 2,700 | 2,727 | +0.41% | 15,700 | 785億3760万 | -3.67% |
06/06 | 2,692 | 2,736 | 2,692 | 2,716 | +0.33% | 59,800 | 782億2080万 | -4.33% |
06/05 | 2,637 | 2,710 | 2,637 | 2,707 | +2.54% | 38,800 | 779億6160万 | -4.98% |
06/04 | 2,592 | 2,673 | 2,550 | 2,640 | -3.72% | 169,900 | 760億3200万 | -7.53% |
06/01 | 2,778 | 2,782 | 2,740 | 2,742 | -2.45% | 34,300 | 789億6960万 | -4.19% |
05/31 | 2,787 | 2,828 | 2,765 | 2,811 | +2.03% | 33,000 | 809億5680万 | -1.75% |
05/30 | 2,789 | 2,789 | 2,733 | 2,755 | -1.82% | 24,400 | 793億4400万 | -3.6% |
05/29 | 2,851 | 2,852 | 2,780 | 2,806 | -1.51% | 26,700 | 808億1280万 | -1.79% |
05/28 | 2,851 | 2,858 | 2,827 | 2,849 | -0.11% | 10,800 | 820億5120万 | -0.25% |
05/25 | 2,932 | 2,932 | 2,851 | 2,852 | -2.16% | 50,200 | 821億3760万 | -0.07% |
05/24 | (IR情報)10:00 スギ花粉症に対するアレルゲン免疫療法薬「シダキュア スギ花粉舌下錠」新発売のお知らせ |
05/24 | 2,879 | 2,939 | 2,855 | 2,915 | +2.39% | 39,500 | 839億5200万 | +2.24% |
05/23 | 2,825 | 2,851 | 2,811 | 2,847 | +0.28% | 17,100 | 819億9360万 | 0% |
05/22 | 2,832 | 2,852 | 2,822 | 2,839 | -0.28% | 11,100 | 817億6320万 | -0.18% |
05/21 | 2,860 | 2,880 | 2,833 | 2,847 | -0.87% | 16,400 | 819億9360万 | +0.18% |
05/18 | 2,900 | 2,900 | 2,868 | 2,872 | -0.62% | 14,600 | 827億1360万 | +1.13% |
05/17 | 2,937 | 2,937 | 2,877 | 2,890 | -1.63% | 16,600 | 832億3200万 | +1.87% |
05/16 | 2,970 | 2,990 | 2,920 | 2,938 | -2.07% | 48,700 | 846億1440万 | +3.6% |
05/15 | 2,969 | 3,035 | 2,953 | 3,000 | +1.01% | 42,600 | 864億 | +5.93% |
05/14 | 2,865 | 2,980 | 2,861 | 2,970 | +3.7% | 30,500 | 855億3600万 | +5.06% |
05/11 | 2,802 | 2,871 | 2,801 | 2,864 | +2.21% | 17,600 | 824億8320万 | +1.49% |
05/10 | 2,810 | 2,818 | 2,794 | 2,802 | -0.21% | 11,200 | 806億9760万 | -0.57% |
05/09 | 2,870 | 2,870 | 2,805 | 2,808 | -2.19% | 17,300 | 808億7040万 | -0.32% |
05/08 | 2,861 | 2,936 | 2,854 | 2,871 | +0.74% | 30,900 | 826億8480万 | +1.92% |
05/07 | 2,850 | 2,871 | 2,815 | 2,850 | -0.45% | 8,500 | 820億8000万 | +1.28% |
05/02 | 2,904 | 2,912 | 2,840 | 2,863 | -1.78% | 19,600 | 824億5440万 | +1.74% |
05/01 | 2,931 | 2,973 | 2,905 | 2,915 | -2.21% | 34,400 | 839億5200万 | +3.77% |
04/27 | 2,860 | 3,005 | 2,832 | 2,981 | +4.38% | 77,000 | 858億5280万 | +6.43% |
04/26 | (IR情報)17:00 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ |
04/26 | (IR情報)15:00 2018年12月期第1四半期決算参考資料 |
04/26 | (IR情報)15:00 平成30年12月期第1四半期決算短信〔日本基準〕(非連結) |
04/26 | 2,808 | 2,935 | 2,795 | 2,856 | +1.71% | 46,100 | 822億5280万 | +2.37% |
04/25 | 2,748 | 2,876 | 2,718 | 2,808 | +3.08% | 40,300 | 808億7040万 | +0.79% |
04/24 | 2,746 | 2,746 | 2,705 | 2,724 | +0.11% | 29,500 | 784億5120万 | -2.12% |
04/23 | 2,778 | 2,778 | 2,713 | 2,721 | -0.66% | 18,400 | 783億6480万 | -2.23% |
04/20 | 2,777 | 2,778 | 2,732 | 2,739 | -1.33% | 15,300 | 788億8320万 | -1.62% |
04/19 | 2,804 | 2,812 | 2,770 | 2,776 | -0.93% | 17,100 | 799億4880万 | -0.32% |
04/18 | (IR情報)10:00 スギ花粉症に対するアレルゲン免疫療法薬「シダキュア スギ花粉舌下錠」の薬価収載のお知らせ |
04/18 | 2,774 | 2,834 | 2,774 | 2,802 | +1.26% | 17,400 | 806億9760万 | +0.57% |